[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.171.146.16. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 674
Citations 0
Viewpoint
April 24, 2019

Outcomes of Percutaneous Coronary Intervention and Coronary Artery Bypass Graft Surgery for Multivessel Coronary Artery Disease: Toward Patient-Centric Decision Making

Author Affiliations
  • 1New York University School of Medicine, New York
  • 2New York Presbyterian Hospital, Columbia University Medical Center, Cardiovascular Research Foundation, New York, New York
JAMA Cardiol. 2019;4(6):507-508. doi:10.1001/jamacardio.2019.1073

The relative outcomes of percutaneous coronary intervention (PCI) and coronary artery bypass graft surgery (CABG) in patients with multivessel coronary artery disease (MVD) have been debated for 3 decades. The essence of this discourse centers on the differential outcomes between these revascularization modalities in (1) procedural morbidity and mortality; (2) long-term protection from death, stroke, and myocardial infarction (MI); and (3) quality of life (including recurrent angina and repeated revascularization). Although numerous trials have evaluated PCI vs CABG in MVD, applying the average treatment effects from these studies to individual patients is challenging, and the rapid evolution of medical, interventional, and surgical approaches has lessened the relevance of these trials to contemporary decision making.

×